Beijing Threatens Retaliation After US Broadens Tech Investment Ban to Biotech

Tense US-China relations are facing fresh pressure from a proposed US rule. This keeps risk elevated for Chinese tech and biotech stocks, including US-listed ADRs and the Hang Seng Tech index. Biotech faces the most direct exposure, as it is the most recently targeted sector and has historically relied on more cross-border funding than sectors already under restrictions. Beijing has not yet specified what countermeasures it might deploy. Uncertainty over the specific response tends to keep investors cautious. The extended public comment period provides room for negotiation, but also stretches the uncertainty over months, potentially weighing on risk appetite for China-exposed assets and the offshore yuan if rhetoric intensifies.

--

The US government is seeking to block its own capital from financing the next wave of Chinese strategic technology. Beijing has indicated it will not let this pass without a response.

The key details from the week are as follows:

• The US Treasury proposed a rule on Thursday that broadens the Outbound Investment Security Program, tightening limits on US investment into hypersonics, quantum technologies, high-performance computing, supercomputing and artificial intelligence directed at China, Russia and North Korea.
• Biotechnology has been added to the targeted industries, an expansion that Treasury Secretary Scott Bessent had requested.
• China's commerce ministry stated on Saturday that the step widens China-related restrictions in a discriminatory fashion, overstretches the concept of national security, and would harm bilateral economic relations.
• Beijing stated it will monitor the situation and reserves the right to take unspecified countermeasures.
• The proposal will undergo a public comment period before a final rule is published.
• Separately, the US State Department this week sanctioned five Chinese firms connected to Linwei Ding, a former Google engineer convicted this year of stealing AI trade secrets. This has drawn additional objections from Beijing.

Beijing has called on Washington to rethink a proposed rule that would tighten restrictions on American investment in China's tech industry. It warned that the measure would damage trade relations and that it maintains the right to respond.

The commerce ministry voiced its strong objection on Saturday. The statement, published by the state-run Global Times and covered by The Hill, saw a spokesperson say the proposal widens China-related investment limits in a discriminatory way. The official described it as a classic case of stretching the national security concept too far. The ministry said it would track further developments, cautioned the rule would hurt bilateral economic ties, and said China reserves the right to take corresponding measures, without specifying them.

Thursday saw the US Treasury Department unveil the proposal. It would extend existing restrictions under the Outbound Investment Security Program covering hypersonic systems, quantum information technologies, high-performance computing, supercomputing and artificial intelligence. The goal of the program is to prevent a small group of designated foreign adversaries—China, Russia and North Korea—from using US capital to enhance their own technological capabilities.

The proposed rule would bring the biotechnology industry within the program's scope. This addition was pushed for by Treasury Secretary Scott Bessent, according to a department press release. Bessent noted the changes would strengthen the program and stop adversaries from using American investments to build critical technologies that pose a threat to US national security.

A public comment period must be completed before the Treasury issues a final version. This leaves room for revisions and for further diplomatic exchanges in the interim.

The proposal comes just days after the State Department imposed sanctions on five Chinese firms tied to Linwei Ding, a former Google engineer convicted earlier this year of stealing artificial-intelligence trade secrets. Beijing also voiced objections to those penalties, saying they severely harm the legitimate rights and interests of Chinese businesses. The two moves together underscore Washington's broadening focus on technology and capital flows as a front in its rivalry with China. The nature of Beijing's eventual response is now the primary variable for investors and policymakers alike.